Outsourcing

1. Early-Phase Whole-Body PK 4/21/2025

   Accelerate your path to the clinic with Aliri’s cost-effective, label-free whole-body PK service — designed to deliver deeper insights, faster decisions, and better outcomes for your drug candidates.

2. What Is Causing Limited Bioavailability 4/21/2025

   Discover how this label-free whole-body QMSI combined with plasma LC-MS/MS can help identify the root causes of limited bioavailability and guide smarter optimization strategies early in development.

3. Minaris Advanced Therapies Philadelphia Campus Overview 5/20/2024

   Our Philadelphia Campus serves as a centralized hub for collaborative efforts, supporting numerous companies throughout the CGT pipeline, from initial research to commercial-scale manufacturing.

4. Get To Know Minaris Advanced Therapies Testing Services 3/21/2024

   Learn how we can help you move your pipeline forward, whether you manufacture with us at Minaris Advanced Therapies, in-house, or with one of our fellow CDMOs.

5. Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility 10/7/2022

   Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.

6. Closing Ancillary Processes: The New Bottleneck In Cell and Gene Therapy 4/15/2021

   One of the continued challenges for scalable commercial manufacturing of cell therapies is closing and automating the entire manufacturing process. Many core manufacturing processes may be closed, but peripheral systems e.g. media formulation, viral vector packaging remain open – introducing opportunities for failures. Invetech’s approach enables manufacturers to close and integrate both core and peripheral processes.

7. Selecting The Right CMO For Your Gene Therapy 5/15/2020

   Find out what criteria makes a great CMO partner and how to know if it is the right one for your gene therapy.